KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bio-Rad Laboratories (BIO) Receivables - Net (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Receivables - Net for 17 consecutive years, with $460.6 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 1.79% to $460.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $460.6 million through Dec 2025, up 1.79% year-over-year, with the annual reading at $460.6 million for FY2025, 1.79% up from the prior year.
  • Receivables - Net for Q4 2025 was $460.6 million at Bio-Rad Laboratories, down from $464.7 million in the prior quarter.
  • The five-year high for Receivables - Net was $498.3 million in Q1 2023, with the low at $399.3 million in Q2 2021.
  • Average Receivables - Net over 5 years is $452.5 million, with a median of $455.0 million recorded in 2023.
  • The sharpest move saw Receivables - Net increased 16.79% in 2022, then dropped 10.73% in 2024.
  • Over 5 years, Receivables - Net stood at $423.5 million in 2021, then grew by 16.79% to $494.6 million in 2022, then fell by 1.14% to $489.0 million in 2023, then fell by 7.46% to $452.5 million in 2024, then increased by 1.79% to $460.6 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $460.6 million, $464.7 million, and $469.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.